1. Stories /
  2. Healthcare /
  3. Quintiles /
75% growth in employee numbers
Quintiles image
Quintiles NEW

Transformational growth to become the world’s largest provider of life sciences product development and integrated healthcare services

USA Flag New 05
Investment date

2008 - 2016

Good to great


EBITDA increased from $370m to $830m
3I Revenue Regeration

Near doubling of revenue from $2.8bn to $4.5bn; EBITDA grew over 250%


growth in employee numbers
3I People

Expanded the global employee base from c.20,000 to c.35,000 employees


acquisitions during ownership
3I Refresh

Operates in over 100 countries

Listed on the NYSE in May 2013, becoming a member of the FORTUNE 500, and named in FORTUNE’s list of the “World’s Most Admired Companies”

Key events under our ownership

Completed nine acquisitions, expanded commercial services into the Middle East, North Africa and East Africa, and developed numerous clinical development and joint venture partnerships
Expanded Real-World & Late Phase offering through acquisition (Outcome Sciences) and strategic partnerships
Created end-to-end product development solution through the Q2 Solutions joint-venture with Quest Diagnostics
Helped develop or commercialise most of the top biopharmaceutical and biologic products on the market today